Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 2001;103:2236-2241

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liuzzo, G.
Right arrow Articles by Maseri, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liuzzo, G.
Right arrow Articles by Maseri, A.
Related Collections
Right arrow Acute coronary syndromes

(Circulation. 2001;103:2236.)
© 2001 American Heart Association, Inc.

Clinical Investigation and Reports

Enhanced Response of Blood Monocytes to In Vitro Lipopolysaccharide-Challenge in Patients With Recurrent Unstable Angina

Giovanna Liuzzo, MD, PhD; Dominick J. Angiolillo, MD; Antonino Buffon, MD; Vittoria Rizzello, MD; Christian Colizzi, MD; Francesca Ginnetti, PhD; Luigi M. Biasucci, MD; Attilio Maseri, MD

From the Department of Cardiology, Catholic University, Rome, Italy

Correspondence to Giovanna Liuzzo, MD, PhD, Cardiology, Catholic University, Largo A. Gemelli, 8-00168 Rome, Italy. E-mail gliuzzo{at}hotmail.com

Background—C-reactive protein (CRP) plasma levels have been associated with short- and long-term occurrence of coronary events. We investigated whether circulating inflammatory cell responsiveness to low-grade stimuli could contribute to the reported association between CRP and coronary events.

Methods and Results—We studied 32 patients with unstable angina who were followed for 24 months and were free of symptoms for 6 months (group 1): 19 patients had persistently high CRP levels (>0.3 mg/dL) (group 1A); 13 patients had normal CRP levels (group 1B). During the follow-up, 12 (63%) group 1A but no group 1B patients developed an infarction or recurrence of unstable angina (P<0.001). Eighteen patients with chronic stable angina (group 2) and 18 healthy subjects (group 3) were studied as controls. Interleukin (IL)-6 production (median, range) by peripheral blood mononuclear cells after 4 hours of in vitro stimulation with 1 ng/mL lipopolysaccharide (LPS) was significantly higher in group 1A (4526 pg/mL, 3042 to 10 583 pg/mL) than in group 1B (1752 pg/mL, 75 to 3981 pg/mL), group 2 (707 pg/mL, 41 to 3275 pg/mL), and group 3 (488 pg/mL, 92 to 3503 pg/mL) (all P<0.001). No significant differences were observed among the other groups. IL-6 production after LPS-challenge was correlated with baseline CRP levels (r=0.42, P=0.005).

Conclusions—Mononuclear cells of patients with recurrent phases of instability exhibit an enhanced production of IL-6 in response to low-dose of LPS, correlated with baseline CRP levels, 6 months after the last acute event. This persisting enhanced acute-phase responsiveness may help explain the association between CRP and acute coronary events.


Key Words: angina • inflammation • interleukins • leukocytes • prognosis




This article has been cited by other articles:


Home page
 HeartHome page
D Versteeg, I E Hoefer, A H Schoneveld, D P V de Kleijn, E Busser, C Strijder, M Emons, P R Stella, P A Doevendans, and G Pasterkamp
Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve
Heart, June 1, 2008; 94(6): 770 - 776.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Liuzzo, L. M. Biasucci, G. Trotta, S. Brugaletta, M. Pinnelli, G. Digianuario, V. Rizzello, A. G. Rebuzzi, C. Rumi, A. Maseri, et al.
Unusual CD4+CD28null T Lymphocytes and Recurrence of Acute Coronary Events
J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1450 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. K. Ray, D. A. Morrow, M. S. Sabatine, A. Shui, N. Rifai, C. P. Cannon, and E. Braunwald
Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome
Circulation, June 19, 2007; 115(24): 3071 - 3078.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
G Liuzzo, G Giubilato, and M Pinnelli
T cells and cytokines in atherogenesis
Lupus, September 1, 2005; 14(9): 732 - 735.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
H. Methe, S. Brunner, D. Wiegand, M. Nabauer, J. Koglin, and E. R. Edelman
Enhanced T-Helper-1 Lymphocyte Activation Patterns in Acute Coronary Syndromes
J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1939 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Methe, J.-O. Kim, S. Kofler, M. Weis, M. Nabauer, and J. Koglin
Expansion of Circulating Toll-Like Receptor 4-Positive Monocytes in Patients With Acute Coronary Syndrome
Circulation, May 24, 2005; 111(20): 2654 - 2661.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
L M Biasucci, M Lombardi, M Piro, G Di Giannuario, G Liuzzo, and F Crea
Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina
Heart, May 1, 2005; 91(5): 670 - 671.
[Full Text] [PDF]

Home page
 CirculationHome page
M. Valgimigli, C. Ceconi, P. Malagutti, E. Merli, O. Soukhomovskaia, G. Francolini, G. Cicchitelli, A. Olivares, G. Parrinello, G. Percoco, et al.
Tumor Necrosis Factor-{alpha} Receptor 1 Is a Major Predictor of Mortality and New-Onset Heart Failure in Patients With Acute Myocardial Infarction: The Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) Study
Circulation, February 22, 2005; 111(7): 863 - 870.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
R Arroyo-Espliguero, P Avanzas, S Jeffery, and J C Kaski
CD14 and toll-like receptor 4: a link between infection and acute coronary events?
Heart, September 1, 2004; 90(9): 983 - 988.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Monakier, M. Mates, M. W. Klutstein, J. A. Balkin, B. Rudensky, D. Meerkin, and D. Tzivoni
Rofecoxib, a COX-2 Inhibitor, Lowers C-Reactive Protein and Interleukin-6 Levels in Patients With Acute Coronary Syndromes
Chest, May 1, 2004; 125(5): 1610 - 1615.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
W. Koenig, N. Khuseyinova, M. M. Hoffmann, W. Marz, M. Frohlich, A. Hoffmeister, H. Brenner, and D. Rothenbacher
CD14 C(-260)->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease
J. Am. Coll. Cardiol., July 3, 2002; 40(1): 34 - 42.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. K. Halushka and P. V. Halushka
Why Are Some Individuals Resistant to the Cardioprotective Effects of Aspirin?: Could It Be Thromboxane A2?
Circulation, April 9, 2002; 105(14): 1620 - 1622.
[Full Text] [PDF]

Home page
 CirculationHome page
K. K. Ray, A. M. Lincoff, E. J. Topol, D. J. Kereiakes, M. A. Mascelli, L. I. Deckelbaum, E. S. Barnathan, K. K. Patel, B. Frederick, and M. T. Nakada
Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization * Response
Circulation, March 26, 2002; 105 (12): e74 - e74.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
A. Maseri and D. Cianflone
Inflammation in acute coronary syndromes
Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B8 - B13.
[Abstract] [PDF]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.